Daria Ostroverkhova

Dr. Daria Ostroverkhova

Department of Bioengineering, M.V. Lomonosov Moscow State University
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Nurbubu MoldogazievaNurbubu Moldogazieva
Nurbubu Moldogazieva
DODaria Ostroverkhova
Daria Ostroverkhova
NKNikolay Kuzmich
Nikolay Kuzmich
VKVladimir Kadochnikov
Vladimir Kadochnikov
ATAlexander A. Terentiev
Alexander A. Terentiev
YPYuri Porozov
Yuri Porozov
Alpha-fetoprotein (AFP) is a major embryo- and tumor-associated protein capable of binding and transporting a variety of hydrophobic ligands, including estrogens. AFP has been shown to inhibit estrogen receptor (ER)-positive tumor growth, which can be attributed to its estrogen-binding ability. Despite AFP having long been investigated, its three-dimensional (3D) structure has not been experimentally resolved and molecular mechanisms underlying AFP–ligand interaction remains obscure. In our study, we constructed a homology-based 3D model of human AFP (HAFP) with the purpose of molecular docking of ERα ligands, three agonists (17β-estradiol, estrone and diethylstilbestrol), and three antagonists (tamoxifen, afimoxifene and endoxifen) into the obtained structure. Based on the ligand-docked scoring functions, we identified three putative estrogen- and antiestrogen-binding sites with different ligand binding affinities. Two high-affinity binding sites were located (i) in a tunnel formed within HAFP subdomains IB and IIA and (ii) on the opposite side of the molecule in a groove originating from a cavity formed between domains I and III, while (iii) the third low-affinity binding site was found at the bottom of the cavity. Here, 100 ns molecular dynamics (MD) simulation allowed us to study their geometries and showed that HAFP–estrogen interactions were caused by van der Waals forces, while both hydrophobic and electrostatic interactions were almost equally involved in HAFP–antiestrogen binding. Molecular mechanics/Generalized Born surface area (MM/GBSA) rescoring method exploited for estimation of binding free energies (ΔGbind) showed that antiestrogens have higher affinities to HAFP as compared to estrogens. We performed in silico point substitutions of amino acid residues to confirm their roles in HAFP–ligand interactions and showed that Thr132, Leu138, His170, Phe172, Ser217, Gln221, His266, His316, Lys453, and Asp478 residues, along with two disulfide bonds (Cys224–Cys270 and Cys269–Cys277), have key roles in both HAFP–estrogen and HAFP–antiestrogen binding. Data obtained in our study contribute to understanding mechanisms underlying protein–ligand interactions and anticancer therapy strategies based on ERα-binding ligands.

9 July 2020 in Cells
Verified
Journal Article
Open access
PDF file
DODaria Ostroverkhova
Daria Ostroverkhova
JHJunda Hu
Junda Hu
VTVadim V. Tarasov
Vadim V. Tarasov
TMTatiana I. Melnikova
Tatiana I. Melnikova
YPYuri Porozov
Yuri Porozov
KMKerim Mutig
Kerim Mutig
The kidney is essential for systemic calcium homeostasis. Urinary calcium excretion can be viewed as an integrative renal response to endocrine and local stimuli. The extracellular calcium-sensing receptor (CaSR) elicits a number of adaptive reactions to increased plasma Ca2+ levels including the control of parathyroid hormone release and regulation of the renal calcium handling. Calcium reabsorption in the distal nephron of the kidney is functionally coupled to sodium transport. Apart from Ca2+ transport systems, CaSR signaling affects relevant distal Na+-(K+)-2Cl− cotransporters, NKCC2 and NCC. NKCC2 and NCC are activated by a kinase cascade comprising with-no-lysine [K] kinases (WNKs) and two homologous Ste20-related kinases, SPAK and OSR1. Gain-of-function mutations within the WNK-SPAK/OSR1-NKCC2/NCC pathway lead to renal salt retention and hypertension, whereas loss-of-function mutations have been associated with salt-losing tubulopathies such as Bartter or Gitelman syndromes. A Bartter-like syndrome has been also described in patients carrying gain-of-function mutations in the CaSR gene. Recent work suggested that CaSR signals via the WNK-SPAK/OSR1 cascade to modulate salt reabsorption along the distal nephron. The review presented here summarizes the latest progress in understanding of functional interactions between CaSR and WNKs and their potential impact on the renal salt handling and blood pressure.

18 August 2020
Verified
Book Chapter
Closed access
PDF file
YSYaroslav V. Solovev
Yaroslav V. Solovev
DODaria Ostroverkhova
Daria Ostroverkhova
GTGaik Tamazian
Gaik Tamazian
ADAnton V. Domnin
Anton V. Domnin
Anastasia A. AnashkinaAnastasia A. Anashkina
Anastasia A. Anashkina
YPYuri Porozov
Yuri Porozov

13 August 2025 in bioRxiv
Verified
Preprint
Open access
DODaria Ostroverkhova
Daria Ostroverkhova
YSYiru Sheng
Yiru Sheng
IRIgor Rogozin
Igor Rogozin
APAnna Panchenko
Anna Panchenko
Cancer can develop through the accumulation of somatic mutations that drive uncontrolled cell proliferation. A central objective in cancer research is to identify mutations that provide a selective growth advantage to tumor cells, so called driver mutations. Many computational methods infer driver missense mutations in proteins by assessing their recurrence. However, such approach suffers from the limited capacity to detect those driver mutations that occur infrequently across tumor samples. One strategy to overcome this limitation is to aggregate mutations from proteins sharing the same protein domain. Here we constructed a benchmark of cancer driver and passenger mutations, based on the known experimental and clinical studies, and systematically evaluated the applicability of methods that aggregate mutations across different mutation types and protein domains. We found that accounting for evidence mutations from different types of amino acid substitutions occurring in the same protein position enhances the classification performance. Furthermore, accounting for evidence mutations from paralogous proteins in the domain family increased the precision but compromised the overall classification accuracy. In addition, the performance of domain-based approaches was shown to crucially depend on the similarity between the target and evidence proteins.